Paper Details

  1. Home
  2. Paper Details

New and Emerging Systemic Treatments for Atopic Dermatitis.

Author: BaloghEsther A, BashyamArjun M, FeldmanSteven R, NewsomMegan, StrowdLindsay C

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Atopic dermatitis (AD) is a common skin condition. This article reviews new treatments for AD, including those targeting IL-13, IL-31, OX40, and the Janus kinase family of proteins.
Paper Details　
Original Abstract of the Article :
Atopic dermatitis (AD) is a prevalent inflammatory skin condition that, depending on its severity, can cause enormous morbidity. Corticosteroids and systemic immunosuppression, traditionally standard of care for difficult-to-treat disease, have many undesirable side effects. The desire for targeted ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281689/

データ提供：米国国立医学図書館（NLM）

New and Emerging Systemic Treatments for Atopic Dermatitis

Living with atopic dermatitis (AD) can feel like navigating a desert of itchy, inflamed skin. This review delves into the exciting world of emerging systemic treatments, exploring new avenues for combating this challenging condition. The authors discuss novel agents targeting specific pathways involved in AD pathogenesis, offering hope for improved treatment options.

A New Era of Targeted Treatments

The review, like a skilled desert navigator mapping a new route, explores the potential of emerging treatments for AD. The authors highlight the advantages of targeted therapies, which aim to address the root causes of AD with greater precision and potentially fewer side effects.

A Promise of Relief for Atopic Dermatitis Sufferers

This review offers a glimpse into a future where more effective and targeted treatments for AD could provide significant relief for those struggling with this condition. The development of these new agents represents a significant step forward in the fight against this chronic and often debilitating disease.

Dr.Camel's Conclusion

This research, like a beacon of hope in the desert of AD, highlights the promise of personalized medicine. The emergence of new and innovative treatments offers a brighter future for those living with this challenging condition.
Date :
  1. Date Completed 2021-05-03
  2. Date Revised 2022-02-18
Further Info :

Pubmed ID

32519223

DOI: Digital Object Identifier

PMC7281689

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.